Zdrowie i gospodarka · 22/01/2020

FDA Classifies Radiological Computer-Assisted Diagnostic Software for Cancer Lesions into Class II with Special Controls

The FDA has classified radiological computer-assisted diagnostic software for lesions suspicious for cancer into Class II with special controls, aiming to ensure safety and effectiveness while reducing regulatory burdens and enhancing patient access to innovative devices.